Brainstorming
Current Research
Topics of interest
ZetaBio Review Series, Part V: "Nano-oncology Meets Organoids: Advancing Drug Screening and Personalized Therapeutics"
Posted: June 2025
Status: Open
ID: T2506-015
ZetaBio Review Series, Part IV: "Targeting the Cancer Cell: Molecular Pathways and Emerging Therapeutic Strategies"
Posted: June 2025
Status: In progress
ID: T2506-014
ZetaBio Review Series, Part III: "3D Cancer Models: From Spheroids to Patient-Derived Organoids"
Posted: June 2025
Status: Open
ID: T2506-013
ZetaBio Review Series, Part II: "Tumor Microenvironment: Architecture, Interactions, and Implications for Therapy"
Posted: June 2025
Status: Open
ID: T2506-012
ZetaBio Review Series, Part I: "Healthy and Cancer Breast Cell: Structure, Function, and Malignant Transformation"
Posted: June 2025
Status: In progress
ID: T2506-011
Hybrid and Bioengineered Liposomal Systems for Breast Cancer: From Lipid Design to Biopolymer Integration and Smart Delivery
Posted: June 2025
Status: Submitted – Under review
ID: T2506-016
High-Throughput Screening of Patient-Derived Organoids for Drug Repurposing in Breast Cancer
Posted: June 2025
Status: Open
ID: T2506-010
3D Organoid Models for Personalized Drug Screening
Posted: May 2025
Status: Open
ID: T2506-009
AI-Driven Organoid Models for Personalized Breast Cancer Therapy
Posted: May 2025
Status: Open
ID: T2506-008
Vascularized Tumor-on-a-Chip for Metastasis and Drug Screening
Posted: May 2025
Status: Open
ID: T2506-007
3D Bioprinted Vascularized Breast Cancer Models for Drug Testing
Posted: May 2025
Status: Open
ID: T2506-006
Current state-of-the-art on Multi-Organ-on-a-Chip Platforms
Posted: May 2025
Status: Open
ID: T2506-005
Hybrid Microfluidic-Liposome Drugs for Enhanced Tumoroid Penetration
Posted: May 2025
Status: Open
ID: T2506-004
Autophagy Inhibition to Prevent Breast Cancer Brain Metastases
Posted: May 2025
Status: Open
ID: T2505-003
Cerebral Organoid Models for Studying Breast Cancer Brain Metastasis
Posted: May 2025
Status: Open
ID: T2505-002
Cerebral Organoid Models for Studying Breast Cancer Brain Metastasis
Posted: May 2025
Status: Open
ID: T2505-001
Nanocarrier Design & Engineering
Development and optimization of liposomal and polymeric nanocarriers, with a focus on physicochemical stability, functionalization, and drug-loading strategies.
Abdvanced Cell Models for Screening
Implementation of 2D monolayers, 3D spheroids, and tumoroids to evaluate drug efficacy and toxicity in a context that closely mimics in vivo environments.
Acdvanced Cell Models for Screening
Implementation of 2D monolayers, 3D spheroids, and tumoroids to evaluate drug efficacy and toxicity in a context that closely mimics in vivo environments.
Surface Coatings & Smart Delivery
Exploration of stealth coatings (e.g., PEGylation) and stimuli-responsive systems for targeted drug release and improved bioavailability.
In Vitro Drug Evaluation Pipelines
Design of in vitro workflows for high-content screening, imaging, and quantitative analysis of nanodrug performance.
How to get involved
in co-authoring high-impact articles.
01.
Join the group
Interested in contributing? Start by reaching out.
Send us a short message describing your background, current affiliation, and your areas of expertise or interest. Whether you’re a researcher, clinician, student, or industry professional, we’re happy to connect and explore how you can fit into our growing team.
02.
Brainstorm & Align
We’ll get back to you with next steps and help you get started.
Once we understand your profile, we’ll introduce you to our collaborative workspace and align you with an ongoing or upcoming topic. Current topics are predefined by the coordination team to streamline collaboration. You’ll choose one based on your interest, usually for a review article or a position paper.
03.
Contribute & Co-Create
We’ll form small, focused writing teams for each topic.
Each team will be assembled based on complementary expertise. We’ll provide initial guidance, coordinate regular check-ins, and participate in outlining and writing the article.
